Live Breaking News & Updates on International laboratories

Stay updated with breaking news from International laboratories. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Proteomics International Laboratories Ltd Investor Presentation -October 29, 2023 at 06:30 pm EDT

Proteomics International Laboratories Ltd is pleased to release a copy of its latest investor presentation for a non-deal roadshow to institutional investors. *To view the Presentation, please...

Australia , Perth , Western-australia , Dirk-van-dissel , Euroz-hartleys , Proteomics-international-laboratories-ltd , Proteomics-international-laboratories , Proteomics-international , International-laboratories-ltd , International-laboratories , Investor-relations , Markets

Proteomics International Laboratories Ltd (ASX:PIQ) September 2023 Quarterly Activities Report

Proteomics International Laboratories Ltd (ASX:PIQ), a medical technology company at the forefront of precision medicine and predictive diagnostics, is pleased to provide the following update on its business activities for the three months to 30 September 2023 and subsequent to the period end.

Australia , Japan , United-states , Perth , Western-australia , United-kingdom , Australian , Proteomics-international , Proteomics-international-laboratories-ltd , Kidney-research-united-kingdom , Proteomics-international-laboratories

Proteomics International Laboratories Ltd (ASX:PIQ) International Webinar and Q&A

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to invite shareholders, investors and interested parties to an online update on the recent announcement regarding the PromarkerD US Reimbursement Price.

Australia , Perth , Western-australia , Australian , Richard-lipscombe , Proteomics-international-laboratories-ltd , Proteomics-international-laboratories , Proteomics-international , Proteomics-international-webinar , International-webinar , International-laboratories-ltd , Australian-regulatory-decision

Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD US Reimbursement Price & Aus Regulatory Decision

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce a major milestone in the commercialisation of its predictive test for diabetic kidney disease, PromarkerD, with the US Centers for Medicare & Medicaid Services.

Australia , Perth , Western-australia , United-states , American , Americans , Australian , Richard-lipscombe , Australian-therapeutic-goods-administration , American-medical-association , Us-centers-for-medicare-medicaid-services , Medicare-advisory-panel-on-clinical-diagnostic-laboratory

Proteomics International Laboratories Ltd (ASX:PIQ) New Oesophageal Cancer Test Presented at Global Conference

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce its latest results for its novel blood test for oesophageal adenocarcinoma will be presented tomorrow at the 19th ISDE World Congress for Esophageal Diseases.

Canada , United-states , Australia , Perth , Western-australia , Toronto , Ontario , Richard-lipscombe , Proteomics-international , Progression-of-barrett-esophagus-to-cancer-network , Laboratory-developed-test , Proteomics-international-laboratories-ltd

Proteomics International Laboratories Ltd (ASX:PIQ) OxiDx Platform Technology Secures Patent in Japan

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce that its subsidiary OxiDx Pty Ltd has been granted a patent in Japan for its platform technology to measure oxidative stress.

Australia , Japan , Perth , Western-australia , Japanese , Richard-lipscombe , Ian-brown , Proteomics-international-laboratories , Proteomics-international , University-of-western-australia , Oxidx-pty-ltd , Proteomics-international-laboratories-ltd